Evidence-Based Complementary and Alternative Medicine

Research Article

miRNA Regulation Network Analysis in Qianliening Capsule Treatment of Benign Prostatic Hyperplasia

Table 2

Differentially expressed genes between the BPH-1 cells treated with QC (2.5 mg/mL) group and control group.
GenesFold change (QC versus CTR)
CYP1A112.8207
CYP1B18.49316
ALDH3A18.25975
AKR1C16.11892
AKR1C34.37771
EDIL33.87485
SCGB1A13.78913
SEMA5A3.39468
DOCK83.31441
MPPED23.14276
SPINK6−5.87906
KRTAP2-3−4.78595
ANKRD1−4.25824
S1PR1−3.49797
SPINK7−3.34239
DUSP6−3.24443
CA9−3.20190
PTGS2−3.06597
BNIP3−2.82441
IL7R−2.81757
Positive value indicated upregulation and negative value indicated downregulation. Genes expression fold change >2 and value < 0.05 were considered statistically significant. QC: BPH-1 cells treated with QC (2.5 mg/mL) group; CTR: control group. The top 10 different genes are shown.